Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Dosing time affects finasteride's effectiveness and safety in rats.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Plant extracts may help treat hormone-related hair loss.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Clascoterone 1% cream is a promising new treatment for acne.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

Phytoandrogens from plants may help treat low testosterone naturally.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

A new compound was made that might help treat diseases related to male hormones.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.